Help close loopholes in regulating compounders, FDA asks states

The FDA asked state officials to help close gaps in the oversight of compounded drugs following the meningitis outbreak tied to tainted drugs from the New England Compounding Center. The agency's authority should be clear when monitoring the operations of compounding pharmacies, and health officials should act to prevent issues that risk public safety, FDA Commissioner Dr. Margaret Hamburg said. Furthermore, Hamburg said, better training is needed for state regulators, and states and the FDA need to improve sharing of information.

View Full Article in:

Reuters · New York Times (tiered subscription model), The · Tennessean (Nashville) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA